A team of researchers in the US have found that regular infusions of blood plasma from young donors could well be a new treatment option for Alzheimer’s disease. A re...

SOTIO, a biotechnology company owned by the PPF Group, today announced the enrolment of the last patient into the VIABLE study, a global Phase III clinical trial eval...

Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, announced t...

CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has further expanded its Late Phase work in Ja...

Almac Group, the global contract development and manufacturing organisation, today announced the acquisition of 100% shares of BioClin Laboratories, an independent an...

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has been recognized with a CPhI Pharma Award for...

BARCELONA, Spain — 01 November 2017 — Veeva Systems (NYSE: VEEV) today announced it will partner with leading interactive response technology (IRT) vendors to provide...

A study led by the Translational Genomics Research Institute (TGen), UC San Francisco (UCSF) and the Ivy Foundation Early Phase Clinical Trials Consortium has used ge...